AMGEN INC (AMGN) vs. BECTON DICKINSON & CO (BDX) Stock Comparison & Valuation | Edwyn

Edwyn

Edwyn Search companies, tickers, CIKs…⌘K

AMGEN INC (AMGN) vs. BECTON DICKINSON & CO (BDX) Stock Comparison & Valuation | Edwyn

Updated 2026-05-30 22:13 UTC

This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.

AMGN looks fundamentally superior to BDX on margins, growth, and capital efficiency, but the current price already sits near the top of its BDX-implied and historical valuation bands, limiting clear upside.

Actionable Takeaway

If you believe AMGN can sustain its superior margin structure and ROIC while continuing to grow around 10%, then holding or buying on modest pullbacks is reasonable because the earnings multiple is not stretched versus BDX and the implied upside is still positive.

On a relative P/E basis, AMGN at 23.7x trades slightly below BDX at 25.3x, which is consistent with AMGN’s stronger profitability profile. However, the implied price of $359.71 is only 6.8% above the current price of $336.79, and the stock is already near the upper end of both its BDX-implied range and its historical band.

Supporting Metrics

Key Risks

AMGN’s high debt/equity ratio of 6.8x could constrain valuation if refinancing or leverage concerns rise.
AMGN is already near the upper end of its historical band at $303.11-$370.47, limiting multiple expansion.
The lack of FCF margin and Altman Z-Score data reduces visibility into cash generation and distress risk.